Search results for: Measuring and Valuing Outcomes

Measuring and Valuing Outcomes

…and meetings Measuring and valuing health outcomes is arguably what makes health economics such a unique and sometimes controversial discipline. The idea of putting a numerical value on… All content…

Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?

1 February 2024

…Limits to Substitution Between Ecosystem Services and Manufactured Goods and Implications for Social Discounting. Environmental and Resource Economics, 69(1), pp.135–158. 10.1007/s10640-016-0068-5. Freeman, M., Groom, B. and Spackman, M., 2018. Social…

Navigating the Intersection of Healthcare and Environmental Sustainability: ISPOR Europe round-up on the inclusion of environmental impact in HTA

17 January 2024

…practices should be shared and that, to seize opportunities, companies should monitor and respond to public sentiment, proactively address any negative issues, and invest in R&D and technology to deal…

Can lessons from valuing health be useful in valuing development aid?

25 March 2012

…number of strong similarities in the way that people understand poverty and development in different countries and contexts’. Highly valued are physical health and strength, physical safety and security, economic…

Altering the trajectory of HIV in Europe

22 May 2025

…language, and are targeted at both general populations and healthcare professionals, have the potential to educate and reduce prejudice and stigma. Diversifying treatment options: PrEP and antiretroviral therapy (ART) are…

Do child QALYs = adult QALYs? Five reasons why they might not

4 February 2020

Why might differences arise between child and adult QALYs? In the UK, NICE’s science policy and research team is reviewing NICE’s recommendations on child utilities and QALYs. In Australia, the…

The Dynamics of Drug Shortages

9 January 2024

…price change of other products with the same molecule, iii) market concentration, iv) demand and competition, and v) patent expiration), which can be used to determine shortages’ factors and value…

OHE’s AMR consultation response

21 November 2023

…across 17 criteria that cover aspects of clinical effectiveness, global and national needs, pharmacological benefits, and health system benefits. Each criterion is associated with scores and a weight (Figure 1)…

Latest estimates show that 20 people a day die in unrelieved pain across the UK at the end of their lives

26 November 2024

…(and therefore higher deaths), populating ageing, and a higher prevalence of complex multiple chronic illnesses including cancer, dementia and cardiovascular diseases. Of these 436,022 people requiring palliative care in England,…